|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-31
|
$1,889,710
|
$56,691
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
WUMC Cancer and Leukemia Group B
|
2U10CA077440-12
|
$345,040
|
$58,657
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Vitamin D, alcohol, and risk of lymphomas in a prospective cohort of women
|
1R03CA135687-01A1
|
$72,500
|
$21,750
|
Chang, Ellen
|
NORTHERN CALIFORNIA CANCER CENTER
|
|
|
Virotherapy for Relapsed Refractory Multiple Myeloma
|
5R01CA125614-04
|
$245,693
|
$245,693
|
DISPENZIERI, ANGELA
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$4,310
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010183-00580
|
$94,490
|
$4,724
|
McGlynn
|
DCEG (NCI)
|
|
|
VCU Minority-Based CCOP
|
3U10CA052784-19S1
|
$99,999
|
$3,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Minority-Based CCOP
|
5U10CA052784-19
|
$314,164
|
$9,425
|
Roberts, John
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Using the Allergic Immune System to Target Cancer
|
3K22CA111639-03S1
|
$10,667
|
$3,520
|
MOLLICK, JOSEPH
|
STANFORD UNIVERSITY
|
|
|
Use of CCI-779 in multiple myeloma
|
5R21CA121464-02
|
$319,950
|
$319,950
|
LICHTENSTEIN, ALAN
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-25
|
$1,884,250
|
$18,843
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-02
|
$1,463,613
|
$58,545
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-22
|
$83,653
|
$3,346
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
|
U10 Ful Member Application Affiliated with SWOG
|
5U10CA105409-06
|
$215,937
|
$8,637
|
HERBST, ROY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Type 1 MAGE vaccine immunotherapy for multiple myeloma
|
5K01CA115917-04
|
$159,624
|
$159,624
|
Cho, Hearn
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant
|
ZIC BC 011029
|
$141,032
|
$28,206
|
Hakim, Frances
|
CCR (NCI)
|
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-05
|
$1,093,403
|
$109,340
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
|
1R01CA123204-01A2
|
$316,438
|
$316,438
|
Licht, Jonathan
|
NORTHWESTERN UNIVERSITY
|
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-26
|
$841,858
|
$8,419
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-16S1
|
$73,969
|
$5,178
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-16S2
|
$99,471
|
$6,963
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-16S3
|
$83,979
|
$5,879
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-16
|
$5,084,061
|
$355,884
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
|
The Molecular Basis for Bortezomib Activity
|
5R01CA129009-03
|
$304,166
|
$304,166
|
STEWART, A
|
MAYO CLINIC COLL OF MED, MAYO CLINIC AZ
|
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-03
|
$507,986
|
$5,080
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
|
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
|
ZIA BC 010008
|
$330,420
|
$66,084
|
Mock, Beverly
|
CCR (NCI)
|
|
|
The Development of Stat3 Inhibitors
|
5R01CA096652-07
|
$358,327
|
$179,164
|
MCMURRAY, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
The Brooklyn Minority-Based Community Clinical Oncology Program
|
5U10CA114671-03
|
$523,248
|
$5,232
|
Solomon, William
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
ZIA SC 010288
|
$480,016
|
$120,004
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
Targeting the Mitochondria to Treat Lymphoma and Myeloma
|
5K23CA109613-05
|
$131,445
|
$65,723
|
Evens, Andrew
|
NORTHWESTERN UNIVERSITY
|
|
|
Targeting myeloma via dendritic cells
|
5R01CA109465-05
|
$309,925
|
$309,925
|
DHODAPKAR, MADHAV
|
YALE UNIVERSITY
|
|
|
Targeting Epigenomics in Myeloid Neoplasms
|
5K24CA111717-05
|
$150,160
|
$75,080
|
GORE, STEVEN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
|
5R01CA133799-02
|
$353,927
|
$353,927
|
Ghobrial, Irene
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Targeted Therapy of B-cell Malignancies
|
3P01CA103985-04S1
|
$519,832
|
$51,983
|
GOLDENBERG, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
|
SWOG Institutional Grant
|
5U10CA073590-13
|
$110,426
|
$3,313
|
FERNANDEZ, HUGO
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
ZIA CP010183-00560
|
$477
|
$24
|
Gridley
|
DCEG (NCI)
|
|
|
Studies on Monoclonal Gammopathies
|
5P01CA062242-14
|
$1,475,669
|
$1,475,669
|
Jelinek, Diane
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
Studies of Occupational Cancer
|
ZIA CP010120-02060
|
$299,185
|
$59,837
|
Lan, Qing
|
DCEG (NCI)
|
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04021
|
$64,057
|
$3,843
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-10441
|
$63,699
|
$3,185
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
Studies of Atomic Bomb Survivors
|
ZIA CP010134-04016
|
$480,282
|
$24,014
|
Mabuchi, Kiyohitko
|
DCEG (NCI)
|
|
|
Stroger Hospital of Cook County, Department of Surgery,*
|
3U10CA095867-08S1
|
$100,000
|
$1,000
|
Lad, Thomas
|
HEKTOEN INSTITUTE FOR MEDICAL RESEARCH
|
|
|
Stroger Hospital of Cook County, Department of Surgery,*
|
5U10CA095867-08
|
$699,027
|
$6,990
|
LAD, THOMAS
|
HEKTOEN INSTITUTE FOR MEDICAL RESEARCH
|
|
|
Stanford University Cancer Center
|
3P30CA124435-03S1
|
$126,467
|
$1,265
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
Stanford University Cancer Center
|
5P30CA124435-03
|
$1,611,344
|
$16,113
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
5U10CA095968-08
|
$688,991
|
$6,890
|
SAPHNER, THOMAS
|
ST. VINCENT HOSPITAL
|
|
|
ST Louis-Cape Girardeau CCOP
|
5U10CA035128-26
|
$387,630
|
$3,876
|
Sleckman, Bethany
|
ST. JOHN'S MERCY MEDICAL CENTER
|
|
|
SPORE in Myeloma
|
5P50CA100707-07
|
$2,300,000
|
$2,300,000
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Southwest Oncology Group/ University of California,
|
5U10CA046441-22
|
$348,516
|
$13,941
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-24
|
$4,746,162
|
$189,846
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Total relevant funding to Multiple Myeloma for this search: $45,183,304
|
